Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

Javad Garousi, Sarah Lindbo, Johan Nilvebrant, Mikael Åstrand, Jos Buijs, Mattias Sandström, Hadis Honarvar, Anna Orlova, Vladimir Tolmachev, Sophia Hober

Cancer Res (2015) 75 (20): 4364–4371.

https://doi.org/10.1158/0008-5472.CAN-14-3497

Published: 14 October 2015

View articletitled, ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

Includes: Supplementary data

Journal Articles

Radionuclide Therapy of HER2-Positive Microxenografts Using a ¹⁷⁷Lu-Labeled HER2-Specific Affibody Molecule

Vladimir Tolmachev, Anna Orlova, Rikard Pehrson, Joakim Galli, Barbro Baastrup, Karl Andersson, Mattias Sandström, Daniel Rosik, Jörgen Carlsson, Hans Lundqvist, Anders Wennborg, Fredrik Y. Nilsson

Cancer Res (2007) 67 (6): 2773–2782.

https://doi.org/10.1158/0008-5472.CAN-06-1630

Published: 15 March 2007

View articletitled, Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule

Journal Articles

Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors

Anna Orlova, Vladimir Tolmachev, Rikard Pehrson, Malin Lindborg, Thuy Tran, Mattias Sandström, Fredrik Y. Nilsson, Anders Wennborg, Lars Abrahmsén, Joachim Feldwisch

Cancer Res (2007) 67 (5): 2178–2186.

https://doi.org/10.1158/0008-5472.CAN-06-2887

Published: 01 March 2007

View articletitled, Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors

Journal Articles

[¹⁷⁷Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts

Mikael Persson, Lars Gedda, Hans Lundqvist, Vladimir Tolmachev, Hans Nordgren, Per-Uno Malmström, Jörgen Carlsson

Cancer Res (2007) 67 (1): 326–331.

https://doi.org/10.1158/0008-5472.CAN-06-2363

Published: 08 January 2007

View articletitled, [177Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts

Journal Articles

Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Anna Orlova, Mikaela Magnusson, Tove L.J. Eriksson, Martin Nilsson, Barbro Larsson, Ingmarie Höidén-Guthenberg, Charles Widström, Jörgen Carlsson, Vladimir Tolmachev, Stefan Ståhl, Fredrik Y. Nilsson

Cancer Res (2006) 66 (8): 4339–4348.

https://doi.org/10.1158/0008-5472.CAN-05-3521

Published: 17 April 2006

View articletitled, Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Journal Articles

Imaging and therapeutic targeting of HER2-positive tumors using Affibody molecules

Fredrik Y. Nilsson, Anna Orlova, Vladimir Tolmachev, Hans Lundqvist, Jörgen Carlsson, Charles Widström, Mattias Sandström, Rikard Pehrson, Stefan Ståhl, Anders Wennborg, Anders Wennborg, Joachim Feldwisch

Cancer Res (2006) 66 (8_Supplement): 878.

Published: 15 April 2006

View articletitled, Imaging and therapeutic targeting of HER2-positive tumors using Affibody molecules

Journal Articles

Radioimaging of leukemias in a mouse model by a new phage display peptide screened for binding to activated leukocyte integrins.

Tanja-Maria Ranta, Erkki Koivunen, Sami Kaukinen, Heli Valtanen, Vladimir Tolmachev, Kalevi Kairemo

Cancer Res (2004) 64 (7_Supplement): 479.

Published: 01 April 2004

View articletitled, Radioimaging of leukemias in a mouse model by a new phage display peptide screened for binding to activated leukocyte integrins.

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

Radionuclide Therapy of HER2-Positive Microxenografts Using a ¹⁷⁷Lu-Labeled HER2-Specific Affibody Molecule

Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors

[¹⁷⁷Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts

Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Imaging and therapeutic targeting of HER2-positive tumors using Affibody molecules

Radioimaging of leukemias in a mouse model by a new phage display peptide screened for binding to activated leukocyte integrins.

Email alerts

AACR Journals

Update search

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers

Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule

Synthetic Affibody Molecules: A Novel Class of Affinity Ligands for Molecular Imaging of HER2-Expressing Malignant Tumors

[177Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts

Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Imaging and therapeutic targeting of HER2-positive tumors using Affibody molecules

Radioimaging of leukemias in a mouse model by a new phage display peptide screened for binding to activated leukocyte integrins.

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Radionuclide Therapy of HER2-Positive Microxenografts Using a ¹⁷⁷Lu-Labeled HER2-Specific Affibody Molecule

[¹⁷⁷Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts